• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 8, Issue 4
  3. Author

Online ISSN: 2515-8260

Volume8, Issue4

Comparative evaluation of complications and mortality in ST-segment elevation acute myocardial infarction (STEMI) in diabetic and nondiabetic patients

    Dr. Shakeel Akhter

European Journal of Molecular & Clinical Medicine, 2021, Volume 8, Issue 4, Pages 1183-1187

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Background: Diabetes is a universal problem and is becoming a major concern at old age
especially in obese people and in people with sedentary life style. The present study was
conducted to assess complications and mortality in ST-segment elevation acute myocardial
infarction in diabetic and non-diabetic patients.
Materials & Methods:160 consecutive patients of diabetic (group I) and non-diabetic
(group II) having acute ST-segment elevation myocardial infarction (STEMI) of both
genders were included. Treatment was given to all patients.
Results: Age group <44 years had 15 diabetic and 10 non- diabetic, 45-54 years had 25
diabetic and 12 non- diabetic, 55-64 years had 10 diabetic and 20 non- diabetic and >65
years had 40 diabetic and 28 non- diabetics. The site was anterior in 26 and 20, inferior in
38 and 40, inferior+ right ventricular in 20 and 10 and lateral in 6. Mortality was seen in
those in which streptokinase was given in 7 and 3 and streptokinase not given in 15 and 10
in group I and group II respectively (P< 0.05).
Conclusion: With streptokinase administration there was reduction in mortality in diabetic
as well as in non- diabetic. However, diabetics not on streptokinase had higher mortality as
compared to non- diabetics.
Keywords:
    Diabetes STEMI Streptokinase
  • PDF (190 K)
  • XML
(2021). Comparative evaluation of complications and mortality in ST-segment elevation acute myocardial infarction (STEMI) in diabetic and nondiabetic patients. European Journal of Molecular & Clinical Medicine, 8(4), 1183-1187.
Dr. Shakeel Akhter. "Comparative evaluation of complications and mortality in ST-segment elevation acute myocardial infarction (STEMI) in diabetic and nondiabetic patients". European Journal of Molecular & Clinical Medicine, 8, 4, 2021, 1183-1187.
(2021). 'Comparative evaluation of complications and mortality in ST-segment elevation acute myocardial infarction (STEMI) in diabetic and nondiabetic patients', European Journal of Molecular & Clinical Medicine, 8(4), pp. 1183-1187.
Comparative evaluation of complications and mortality in ST-segment elevation acute myocardial infarction (STEMI) in diabetic and nondiabetic patients. European Journal of Molecular & Clinical Medicine, 2021; 8(4): 1183-1187.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 183
  • PDF Download: 177
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus